1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges,
Trends
4. Voice of Customer
5. Global AI in Oncology
Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Component (Software
Solutions, Hardware, Services)
5.2.2. By Cancer Type (Breast Cancer,
Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Others)
5.2.3. By Treatment Type
(Chemotherapy, Radiotherapy, Immunotherapy, Others)
5.2.4. By Region (North America,
Europe, Asia Pacific, South America, Middle East & Africa)
5.2.5. By Company (2024)
5.3. Market Map
6. North America AI in
Oncology Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Component (Software
Solutions, Hardware, Services)
6.2.2. By Cancer Type (Breast Cancer,
Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Others)
6.2.3. By Treatment Type
(Chemotherapy, Radiotherapy, Immunotherapy, Others)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States AI In
Oncology Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By
Component
6.3.1.2.2. By
Cancer Type
6.3.1.2.3. By
Treatment Type
6.3.2. Canada AI In Oncology
Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By
Component
6.3.2.2.2. By
Cancer Type
6.3.2.2.3. By
Treatment Type
6.3.3. Mexico AI In Oncology
Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By
Component
6.3.3.2.2. By
Cancer Type
6.3.3.2.3. By
Treatment Type
7. Europe AI In Oncology
Market Outlook
7.1. Market Size &
Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Component (Software
Solutions, Hardware, Services)
7.2.2. By Cancer Type (Breast Cancer,
Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Others)
7.2.3. By Treatment Type
(Chemotherapy, Radiotherapy, Immunotherapy, Others)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France AI In
Oncology Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By
Component
7.3.1.2.2. By
Cancer Type
7.3.1.2.3. By
Treatment Type
7.3.2. Germany AI In Oncology Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By
Component
7.3.2.2.2. By
Cancer Type
7.3.2.2.3. By
Treatment Type
7.3.3. United Kingdom AI In Oncology
Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By
Component
7.3.3.2.2. By
Cancer Type
7.3.3.2.3. By
Treatment Type
7.3.4. Italy
AI In Oncology Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By
Component
7.3.4.2.2. By
Cancer Type
7.3.4.2.3. By
Treatment Type
7.3.5. Spain AI In
Oncology Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By
Component
7.3.5.2.2. By
Cancer Type
7.3.5.2.3. By
Treatment Type
8. Asia-Pacific AI In
Oncology Market Outlook
8.1. Market Size &
Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Component (Software
Solutions, Hardware, Services)
8.2.2. By Cancer Type (Breast Cancer,
Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Others)
8.2.3. By Treatment Type
(Chemotherapy, Radiotherapy, Immunotherapy, Others)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China AI In
Oncology Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By
Component
8.3.1.2.2. By
Cancer Type
8.3.1.2.3. By
Treatment Type
8.3.2. India AI In Oncology Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By
Component
8.3.2.2.2. By
Cancer Type
8.3.2.2.3. By
Treatment Type
8.3.3. Japan AI
In Oncology Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By
Component
8.3.3.2.2. By
Cancer Type
8.3.3.2.3. By
Treatment Type
8.3.4. South Korea AI In
Oncology Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By
Component
8.3.4.2.2. By
Cancer Type
8.3.4.2.3. By
Treatment Type
8.3.5. Australia AI In
Oncology Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By
Component
8.3.5.2.2. By
Cancer Type
8.3.5.2.3. By
Treatment Type
9. South America AI In
Oncology Market Outlook
9.1. Market Size &
Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Component (Software
Solutions, Hardware, Services)
9.2.2. By Cancer Type (Breast Cancer,
Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Others)
9.2.3. By Treatment Type
(Chemotherapy, Radiotherapy, Immunotherapy, Others)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil AI In Oncology
Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By
Component
9.3.1.2.2. By
Cancer Type
9.3.1.2.3. By
Treatment Type
9.3.2. Argentina AI In Oncology
Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By
Component
9.3.2.2.2. By
Cancer Type
9.3.2.2.3. By
Treatment Type
9.3.3. Colombia AI In Oncology
Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By
Component
9.3.3.2.2. By
Cancer Type
9.3.3.2.3. By
Treatment Type
10. Middle East and Africa AI In Oncology
Market Outlook
10.1. Market
Size & Forecast
10.1.1. By Value
10.2. Market
Share & Forecast
10.2.1. By Component (Software Solutions,
Hardware, Services)
10.2.2. By Cancer Type (Breast Cancer, Lung
Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Others)
10.2.3. By Treatment Type (Chemotherapy,
Radiotherapy, Immunotherapy, Others)
10.2.4. By Country
10.3. MEA:
Country Analysis
10.3.1. South Africa AI In
Oncology Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By
Component
10.3.1.2.2. By
Cancer Type
10.3.1.2.3. By
Treatment Type
10.3.2. Saudi
Arabia AI In Oncology Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By
Component
10.3.2.2.2. By
Cancer Type
10.3.2.2.3. By
Treatment Type
10.3.3. UAE AI In Oncology
Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By
Component
10.3.3.2.2. By
Cancer Type
10.3.3.2.3. By
Treatment Type
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent
Development
12.2. Mergers
& Acquisitions
12.3. Product
Launches
13. Global AI In Oncology Market: SWOT
Analysis
14. Porter’s Five Forces Analysis
14.1. Competition
in the Industry
14.2. Potential
of New Entrants
14.3. Power
of Suppliers
14.4. Power
of Customers
14.5. Threat
of Substitute Products
15. Competitive Landscape
15.1. Azra
AI.
15.1.1. Business Overview
15.1.2. Product Offerings
15.1.3. Recent Developments
15.1.4. Financials (As Reported)
15.1.5. Key Personnel
15.1.6. SWOT Analysis
15.2. IBM
Corp.
15.3. Siemens
Healthcare GmbH.
15.4. Intel
Corporation.
15.5. GE
HealthCare.
15.6. NVIDIA
Corporation.
15.7. Digital
Diagnostics Inc.
15.8. ConcertAI.
15.9. Median
Technologies.
15.10. PathAI.
16. Strategic Recommendations
17. About Us & Disclaimer